Endogenous cannabinoid ligands - Chemical and biological studies

Journal of Lipid Mediators and Cell Signalling

Volumn 14, Issue 1-3, 1996, Pages 45-49

  Mechoulam, R ^a   Ben Shabat, S ^a   Hanus L ^a   Fride, E ^a   Vogel, Z ^b   Bayewitch, M ^b   Sulcova, A E ^c  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^b WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^c MASARYK UNIVERSITY   (Czech Republic)

Author keywords

anandamides; cannabinoid receptor; docostetraenylethanolamide; homo linolenylethanolamide; pedi atrics

Indexed keywords

ADENYLATE CYCLASE; ANANDAMIDE; CANNABINOID RECEPTOR; DRONABINOL; RECEPTOR SUBTYPE;

AGE; ANALGESIA; BRAIN; CONFERENCE PAPER; ENZYME INHIBITION; GENETIC TRANSFECTION; IMMUNE SYSTEM; INTESTINE; LOCOMOTION; MOTOR COORDINATION; MOUSE; NONHUMAN; PEDIATRICS; PRIORITY JOURNAL; RECEPTOR BINDING; SHORT TERM MEMORY; SPLEEN;

EID: 0030248907     PISSN: 09297855     EISSN: None     Source Type: Journal    
DOI: 10.1016/0929-7855(96)01507-6     Document Type: Conference Paper

References (23)

1. Abrahamov, A., Abrahamov, A. and Mechoulam, R. (1995) An efficient new cannabinoid antiemetic in pediatric oncology. Life Sci. 56, 2097-2012.
2. Bayewitch, M., Avidor-Reiss, T., Levy, R., Barg, J., Mechoulam, R. and Vogel, Z. (1995) The peripheral cannabinoid receptor: adenylate cyclase inhibition and G-protein coupling. Febs Lett. 375, 143-147.
3. Belue, R.C., Hewlett, A.C., Westlake, T.M. and Hutchings, D.E. (1994) The ontogeny of cannabinoid receptors in the brain of postnatal and aging rats. Neurotoxicol. Teratol. 17, 25-30.
4. Compton, D.R., Rice, K.C., De Costa, B.R. et al. (1993) Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265; 218-226.
5. Devane, W.A., Hanuš, L., Breuer, A. et al. (1992) Isolation and structure of a brain constitutent that binds to the cannabinoid receptor. Science 258, 1946-1949.
6. Di Marzo, V., Fontana, V., Cadas, H., Schinelli, G.C., Cimino, G., Schwartz, J-C. and Piomelli D. (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372, 686-691.
7. Feigenbaum, J.J., Richmond, S.A., Weissman, Y. and Mechoulam, R. (1989) Inhibition of cisplatin induced emesis in the pigeon by a non-psychotropic synthetic cannabinoid. Eur. J. Pharmacol. 169, 159-165.
8. Fride, E., Barg, J., Levy, R. et al. (1995) Low doses of anandamides inhibit pharmacological effects of delta-9-tetrahydrocannabinol. J. Pharmacol. Exp. Ther. 272, 699-707.
9. Fride, E. and Mechoulam, R. (1993) Pharmacological activity of the cannabinoid agonist anandamide, a brain constituent. Eur. J. Pharmacol. 231, 313-314.
10. Fride, E. and Mechoulam, R. (1996) Developmental aspects of anandamide: ontogeny of response and effects of prenatal exposure to anandamide. Psychoneuroendocrin. 21, 157-172.
11. Hanuš, L., Gopher, A., Almog, S. and Mechoulam, R. (1993) Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor. J. Med. Chem. 36, 3032-3034.
12. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de-Costa, B.R. and Rice, K.C. (1991) Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
13. Howlett, A.C. (1995) Pharmacology of cannabinoid receptors. Ann. Rev. Pharmacol. Toxicol. 35, 607-634.
14. Mackie, K., Devane, W.A. and Hille, B. (1993) Anandamide, an endogenous cannabinoid, inhibits calcium currents as a partial agonist in N18 neuroblastoms cells. Mol. Pharmacol. 44, 498-503.
15. Martin, B.R. (1986) Cellular effects of cannabinoids. Pharmacol. Rev. 38, 45-74.
16. McLaughlin, C.R. and Abood, M.E. (1993) Developmental expression of cannabinoid receptor mRNA. Dev. Brain Res. 76, 75-78.
17. Mechoulam, R., Hanuš, L. and Martin, B.R. (1994) The search for endogenous ligands of the cannabinoid receptor. Biochem. Pharmacol. 48, 1537-1544.
18. Mechoulam, R., Ben-Shabat, S., Hanuš, L. et al. (1995) Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to annabinoid receptors. Biochem. Pharmac. 50, 83-90.
19. Munro, S., Thomas, K.L. and Abu-Shaar, M. (1993) Molecular characterization of a peripheral receptor for cannabinoids. Nature 365, 61-65.
20. Paton, W.D.M. and Pertwee, R.G. (1973) The pharmacology of cannabis in animals. In: Mechoulam, R. (Ed.), Marijuana: Chemistry, Pharmacology, Metabolism and Clinical Effects. Academic Press, New York, pp. 191-285.
21. Sulcova, A.E., Mechoulam, R. and Fride, E. (1996) Biphasic effects of cannabinoid receptor agonists. Submitted.
22. Smith, P.B., Compton, D.R., Welch, S.P., Razdan, R.K., Mechoulam, R. and Martin, B.R. (1994) The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice. J. Pharmacol. Exp. Ther. 270, 219-227.
23. Vogel, Z., Barg, J., Levy, R., Saya, D., Heldman, E. and Mechoulam, R. (1993) Anandamide, a brain endogenous compound, interactis specifically with cannabinoid receptors and inhibits adenylate cyclase. J. Neurochem. 61, 352-355.